# OnCo record mbrace-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mbrace-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mbrace-therapeutics" ;
  schema:name "MBrace Therapeutics"@en ;
  schema:description "MBrace Therapeutics is a United States-based biotechnology company running 2 late-stage cancer trials in prostate cancer, HR-positive / HER2-negative breast cancer and colorectal cancer."@en ;
  schema:url <https://onco.cc/companies/mbrace-therapeutics/>, <https://www.mbracetrx.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.mbracetrx.com>, <https://clinicaltrials.gov/search?lead=MBrace%20Therapeutics> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:trials <https://onco.cc/trials/nct07145255/>, <https://onco.cc/trials/nct06014658/> .